Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-09

FDA Approved: TELMISARTAN AND AMLODIPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for telmisartan and amlodipine from Mylan Pharmaceuticals, enabling the generic combination product to be marketed u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telmisartan and Amlodipine (Telmisartan and Amlodipine)

Snippet

SUPPL AP for TELMISARTAN AND AMLODIPINE (TELMISARTAN AND AMLODIPINE)